Humacyte (HUMA) Scheduled to Report Q3 2026 Earnings Results
Humacyte, Inc. (HUMA) is set to release its third-quarter 2026 financial results on Tuesday, November 10th, prior to the market opening. Market analysts have established a consensus earnings per share (EPS) estimate of -$0.08 and a revenue projection of $0.77 million, representing a modest year-over-year increase of 2.7%. Investor sentiment regarding upcoming figures appears cautious due to recent revisions in analyst expectations. While EPS estimates have remained relatively balanced with one upward and one downward revision over the last three months, revenue forecasts have faced significant pressure, seeing five downward revisions during the same period.
Tickers: $HUMA
Topics: earnings_expectation eps_estimates revenue_estimates